Venture-Backed Startups

Avo develops a clinical AI platform designed for healthcare providers to support evidence-based clinical decision-making while reducing clinician burnout. The platform helps clinicians access medical knowledge and adhere to clinical pathways within their electronic health records.

4 investors

Avoca provides always-on AI voice and messaging agents that handle inbound calls, texts, and chats, run outbound SMS and call campaigns, and score calls for coaching in home and field service businesses. It serves service industries such as HVAC, plumbing, electrical, auto repair, and roofing, and integrates with ServiceTitan as a certified app.

1 investor

Avoca provides AI-powered customer service agents for service-based businesses that handle incoming calls, text messages, and chats to book appointments and re-engage customers. The platform targets HVAC, plumbing, electrical, auto repair, construction, and other service industries with features for call answering, lead capture, customer nurture campaigns, and call coaching.

11 investors

Avoca provides an operational intelligence and automation layer for radiology clinic networks, handling patient calls, referrals, and bookings across channels 24/7 and integrating with existing RIS systems. It manages the patient journey from referral to results to help radiology providers capture demand, retain patients, and scale operations without adding headcount.

1 investor

Avocademy is an online bootcamp that teaches UX/UI design skills to career changers with no prior design experience, preparing them for roles with a job guarantee. The program includes design foundations (8-16 weeks), career services, portfolio building, and interview preparation to help graduates land positions making $85K per year.

3 investors

Avocado is a point-of-sale platform designed for food trucks, coffee shops, and restaurants, offering features including QR code ordering, handheld POS, AI-powered order taking and reporting, and payment processing. The platform charges no monthly or merchant fees.

1 investor

Avocado Systems develops application security software that automates threat detection and elimination to protect enterprises from breaches and advanced threats. The company serves large and small organizations seeking to reduce manual security workloads and improve business agility.

2 investors

Programmatic native ad for mobile publishers (exited)

2 investors

Avochato provides a communication platform that enables businesses to connect with customers through SMS messaging, chat, and voice calls. The platform serves organizations across various industries that seek to improve customer engagement and automate communication workflows.

3 investors

Avocode's products were discontinued as of October 1, 2023, and the domain now points visitors to Ceros. Ceros offers tools to design and publish interactive digital experiences and to collect feedback directly on websites, videos, images, and design files.

2 investors

Avoice provides administrative and workflow management software for architecture and engineering practices, handling specification writing, submittal tracking, RFI coordination, and drawing markup. The platform serves architects and engineers, enabling them to focus on design rather than administrative tasks.

1 investor

Avol operates a drone delivery network for hospitals, flying time-critical medical payloads such as blood, organs, tissue, stem cells, and diagnostics between facilities in temperature-validated, cold-chain containers compatible with UN3373 and OPTN standards. It targets 100-400 mile routes at prices comparable to or below road courier costs, with operations anchored in St. Louis and Brooklyn.

2 investors

0 investors

0 investors

IgniteTech is an enterprise software company that acquires, revitalizes, and supports a portfolio of mission-critical business software for organizations worldwide. Since 2023 it has repositioned as an AI-first company, building AI products such as Eloquens AI, MyPersonas, and Adminio AI and embedding AI capabilities across its acquired software portfolio.

1 investor

Avolon is a global aviation finance company that leases young, fuel-efficient aircraft to airlines worldwide. It connects capital with airline customers, focusing on aircraft leasing to generate returns for shareholders.

1 investor

Avoma is a meeting intelligence platform that automatically captures, transcribes, and analyzes meetings, delivering summaries and key takeaways to Microsoft Teams channels to keep teams aligned. It integrates with Salesforce and HubSpot for CRM sync and provides AI-powered conversation intelligence and speaker insights.

6 investors

0 investors

Avon HMO is a Nigerian health maintenance organization offering individual, family, and corporate health plans that coordinate care and cover medical bills for subscribers. It also provides on-site health risk assessments, occupational health management, employee well-being services, a mobile app (Avon Flex), and an AI WhatsApp chatbot.

1 investor

Avon Medical Practice is a healthcare provider offering end-to-end patient care covering prevention, diagnostics, management, and recovery across all life stages. Part of the Heirs Holdings group, it focuses on expanding access to affordable, quality healthcare in Nigeria and across Africa.

1 investor

Avondale Private Capital is a credit-focused private markets advisory and risk participation firm working in private credit, carbon markets, credit insurance, and impact investing. It serves insurers, banks, pensions, family offices, foundations, hedge funds, alternative lenders, and corporates.

1 investor

Avora provides AI-powered agents for dental practices and groups that automate clinical note-taking, treatment plan coaching, and reporting. The platform helps dental teams reduce administrative time, improve patient treatment acceptance, and scale operations without additional staff hiring.

2 investors

0 investors

Avotres is a private biotechnology company developing cell therapies and monoclonal antibody treatments for autoimmune diseases and cancer. Its lead asset AVT001 targets a regulatory T cell pathway to restore self-tolerance, with clinical programs in Type 1 Diabetes and Multiple Sclerosis, alongside a diagnostic test for autoimmune diseases.

1 investor